BiomX Inc. (NYSEAMERICAN:PHGE) Sees Large Drop in Short Interest

BiomX Inc. (NYSEAMERICAN:PHGE) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totalling 36,400 shares, a decline of 34.4% from the November 30th total of 55,500 shares. Approximately 0.3% of the shares of the company are sold short. Based on an average daily volume of 90,000 shares, the short-interest ratio is presently 0.4 days.

BiomX Stock Up 16.7 %

PHGE traded up $0.11 during midday trading on Friday, reaching $0.75. The company had a trading volume of 228,525 shares, compared to its average volume of 109,006. BiomX has a 12-month low of $0.48 and a 12-month high of $8.55. The stock has a market cap of $13.55 million, a price-to-earnings ratio of -0.23 and a beta of 1.31.

BiomX Company Profile

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).